March 26, 2020

KOMO News 4 Interviews Dr. Ho on COVID-19

Watch Dr. Ho explain how antivirals might only be effective for early stage treatment of COVID-19. KOMO News 4 of Seattle covered the story. For the full talk, follow the link.

News

TLC-ART Lab Update on HIV Therapies at LEAP Conference
Seattle, WA (Feb 12, 2022)–Earlier this month, Dr. Rodney Ho presented updates on the TLC-ART program’s Unitaid funded Global Long-Acting Drug Development (GLAD) Project at the LEAP (Lon-Acting/Extended Release Antiretroviral Research Resource Program) annual meeting. As part of this meeting, Dr. Ho lectured on the progress of the GLAD project …Read »
TLC-ART and MPP sign a licence agreement for a long-acting injectable candidate for HIV
TLC-ART program signs a license agreement with MPP to develop long-acting HIV therapeutics.Read »
FDA Approves TLC Alumnus John Hoekman’s Migraine-Treating Nasal Spray
FDA Approves TLC Alumnus Dr. Hoekman's Migraine Therapy.Read »
TLC-ART Director Dr. Rodney JY Ho Named to National Academy of Inventors
TLC-ART is honored to announce that Director and UWSOP Professor of Pharmaceutics Rodney JY Ho has been elected to the rank of NAI Fellow by the 2020 National Academy of Inventors Fellows Selection Committee and Board of Directors. “Dr. Ho has demonstrated a highly prolific spirit of innovation in creating …Read »
Dr. Ho Talks Pfizer and COVID-19 Vaccine Distribution with KOMO News 4
Dr. Rodney Ho, Executive Director of WE-REACH, discussed the Pfizer COVID-19 vaccine and the challenges of distributing a treatment that requires -80 degree Celsius freezer storage with KOMO News last Friday. While “it is logistically challenging,” Dr. Ho believes that “we have prepared the best as we can.” For the …Read »
Drug Topics Covers HIV, COVID-19, and the Role of Pharmacists with Dr. Ho
Drug Topics, a major publication for pharmacists with over 150,000 readers, recently spoke with Dr. Ho about the crucial role of pharmacists in treating the dual crises of COVID-19 and HIV. With the rise of telehealth and the need to understand drug-drug interactions, pharmacists have never been more important for …Read »

KOMO News 4 Interviews Dr. Ho on COVID-19

News

TLC-ART Lab Update on HIV Therapies at LEAP Conference

TLC-ART and MPP sign a licence agreement for a long-acting injectable candidate for HIV

FDA Approves TLC Alumnus John Hoekman’s Migraine-Treating Nasal Spray

TLC-ART Director Dr. Rodney JY Ho Named to National Academy of Inventors

Dr. Ho Talks Pfizer and COVID-19 Vaccine Distribution with KOMO News 4

Drug Topics Covers HIV, COVID-19, and the Role of Pharmacists with Dr. Ho

Be boundless

Connect with us: